CS117692A3 - Heterocyclic amides, process of their preparation and pharmaceuticalcompositions containing such amides - Google Patents

Heterocyclic amides, process of their preparation and pharmaceuticalcompositions containing such amides Download PDF

Info

Publication number
CS117692A3
CS117692A3 CS921176A CS117692A CS117692A3 CS 117692 A3 CS117692 A3 CS 117692A3 CS 921176 A CS921176 A CS 921176A CS 117692 A CS117692 A CS 117692A CS 117692 A3 CS117692 A3 CS 117692A3
Authority
CS
Czechoslovakia
Prior art keywords
group
formula
dichloromethane
pyridyl
compound
Prior art date
Application number
CS921176A
Other languages
Czech (cs)
English (en)
Inventor
Peter Robert Bernstein
Andrew Shaw
Royston Martin Thomas
Peter Warner
Donald John Wolanin
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919108358A external-priority patent/GB9108358D0/en
Priority claimed from GB919108357A external-priority patent/GB9108357D0/en
Priority claimed from GB929205392A external-priority patent/GB9205392D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of CS117692A3 publication Critical patent/CS117692A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
CS921176A 1991-04-18 1992-04-16 Heterocyclic amides, process of their preparation and pharmaceuticalcompositions containing such amides CS117692A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919108358A GB9108358D0 (en) 1991-04-18 1991-04-18 Heterocyclic compounds
GB919108357A GB9108357D0 (en) 1991-04-18 1991-04-18 Heterocyclic amides
GB929205392A GB9205392D0 (en) 1992-03-12 1992-03-12 Heterocyclic amides

Publications (1)

Publication Number Publication Date
CS117692A3 true CS117692A3 (en) 1992-11-18

Family

ID=27265602

Family Applications (1)

Application Number Title Priority Date Filing Date
CS921176A CS117692A3 (en) 1991-04-18 1992-04-16 Heterocyclic amides, process of their preparation and pharmaceuticalcompositions containing such amides

Country Status (15)

Country Link
EP (1) EP0509769B1 (ko)
JP (1) JPH0656785A (ko)
KR (1) KR920019750A (ko)
AU (1) AU660664B2 (ko)
CA (1) CA2065794A1 (ko)
CS (1) CS117692A3 (ko)
DE (1) DE69213537T2 (ko)
FI (1) FI921598A (ko)
GB (1) GB9207145D0 (ko)
HU (1) HUT66541A (ko)
IE (1) IE921159A1 (ko)
IL (1) IL101555A0 (ko)
NO (1) NO921451L (ko)
NZ (1) NZ242322A (ko)
TW (1) TW262475B (ko)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521179A (en) * 1991-04-18 1996-05-28 Zeneca Limited Heterocyclic amides
GB9307555D0 (en) * 1992-04-16 1993-06-02 Zeneca Ltd Heterocyclic compounds
US5441960A (en) * 1992-04-16 1995-08-15 Zeneca Limited 1-pyrimidinylacetamide human leukocyte elastate inhibitors
ATE158588T1 (de) * 1992-04-16 1997-10-15 Zeneca Ltd Peptide mit eine alphaaminoboronaire gruppe and ihre verwendung als elastasehemmer
US5486529A (en) * 1992-04-16 1996-01-23 Zeneca Limited Certain pyridyl ketones for treating diseases involving leukocyte elastase
EP0636144A1 (en) * 1992-04-16 1995-02-01 Zeneca Limited Alpha-aminoboronic acid peptides and their use as elastase inhibitors
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9214053D0 (en) * 1992-07-02 1992-08-12 Ici Plc Heterocyclic amides
US5658930A (en) * 1994-12-13 1997-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5656645A (en) * 1994-12-13 1997-08-12 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US6608204B1 (en) * 1994-12-13 2003-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
CN1131210C (zh) * 1995-04-27 2003-12-17 三菱制药株式会社 杂环类酰胺化合物及其医药用途
WO1997001338A1 (en) * 1995-06-27 1997-01-16 Merck & Co., Inc. Pyridinone-thrombin inhibitors
US5668289A (en) * 1996-06-24 1997-09-16 Merck & Co., Inc. Pyridinone thrombin inhibitors
US5872138A (en) * 1996-09-13 1999-02-16 Merck & Co., Inc. Thrombin inhibitors
US5869487A (en) * 1996-10-24 1999-02-09 Merck & Co., Inc. Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
EP0940400A4 (en) * 1996-10-25 2002-10-02 Mitsubishi Pharma Corp NOVEL HETEROCYCLIC AMIDE COMPOUNDS AND THEIR USE FOR MEDICINAL PURPOSES
US6017934A (en) * 1997-01-22 2000-01-25 Merck & Co., Inc. Thrombin inhibitors
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
US6011038A (en) * 1997-09-05 2000-01-04 Merck & Co., Inc. Pyrazinone thrombin inhibitors
US6087373A (en) * 1997-09-23 2000-07-11 Merck & Co., Inc. Thrombin inhibitors
US6133297A (en) * 1997-09-30 2000-10-17 Merck & Co., Inc. Thrombin inhibitors
CN1160075C (zh) 1998-03-11 2004-08-04 卫福有限公司 杂环酰胺化合物在制备IgE抗体产生抑制剂中的用途
US6147078A (en) * 1998-05-19 2000-11-14 Merck & Co., Inc. Pyrazinone thrombin inhibitors
EP1117660A4 (en) * 1998-09-28 2002-01-09 Merck & Co Inc THROMBIN INHIBITORS
AU752186B2 (en) 1998-10-30 2002-09-12 Merck & Co., Inc. Thrombin inhibitors
EP1124822A4 (en) 1998-10-30 2002-04-03 Merck & Co Inc THROMBIN INHIBITORS
US6239132B1 (en) 1999-04-23 2001-05-29 Merck & Co., Inc. Thrombin inhibitors
UA58636C2 (uk) 1999-06-04 2003-08-15 Мерк Енд Ко., Інк. Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням
WO2000074682A1 (en) 1999-06-04 2000-12-14 Merck & Co., Inc. Thrombin inhibitors
AU2044401A (en) 1999-11-23 2001-06-04 Merck & Co., Inc. Pyrazinone thrombin inhibitors
EP1267876A1 (en) 2000-03-23 2003-01-02 Merck & Co., Inc. Thrombin inhibitors
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
PE20050159A1 (es) 2003-05-27 2005-04-19 Vertex Pharma Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa
SE0302487D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
ATE543803T1 (de) 2004-11-24 2012-02-15 Vertex Pharma 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren
CA2610400A1 (en) * 2005-06-07 2006-12-14 Pharmacopeia, Inc. Azinone and diazinone v3 inhibitors for depression and stress disorders
MX2007015419A (es) * 2005-06-08 2008-02-21 Novartis Ag Compuestos organicos.
CN110950807B (zh) * 2018-09-26 2023-03-03 中国科学院上海药物研究所 联芳基类化合物、其制备方法、药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474778A (en) * 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives

Also Published As

Publication number Publication date
DE69213537T2 (de) 1997-02-20
JPH0656785A (ja) 1994-03-01
NZ242322A (en) 1994-12-22
FI921598A (fi) 1992-10-19
IL101555A0 (en) 1992-12-30
GB9207145D0 (en) 1992-05-13
IE921159A1 (en) 1992-10-21
NO921451L (no) 1992-10-19
EP0509769B1 (en) 1996-09-11
HUT66541A (en) 1994-12-28
EP0509769A3 (en) 1993-09-01
HU9201225D0 (en) 1992-07-28
AU660664B2 (en) 1995-07-06
AU1482792A (en) 1992-10-22
CA2065794A1 (en) 1992-10-19
NO921451D0 (no) 1992-04-10
EP0509769A2 (en) 1992-10-21
DE69213537D1 (de) 1996-10-17
KR920019750A (ko) 1992-11-19
FI921598A0 (fi) 1992-04-10
TW262475B (en) 1995-11-11

Similar Documents

Publication Publication Date Title
CS117692A3 (en) Heterocyclic amides, process of their preparation and pharmaceuticalcompositions containing such amides
TWI586651B (zh) 作為因子ｘｉａ抑制劑之經取代四氫異喹啉化合物
US5948785A (en) Heterocyclic amide compounds and pharmaceutical use of the same
CZ251792A3 (en) 1-pyrimidinylacetamide derivatives, process of their preparation and pharmaceutical compositions in which said derivatives are comprised
JP5645834B2 (ja) 嚢胞性線維症膜コンダクタンス制御因子の修飾因子
RU2301231C2 (ru) Полициклическое соединение, фармацевтическая композиция, обладающая свойствами антагониста рецептора h3, и способ лечения с его применением
JP4491072B2 (ja) ビトロネクチンレセプター拮抗物質
ES2221213T3 (es) Inhibidores de kinasa biciclicos.
JP5314050B2 (ja) ４−ピリジノン化合物および癌についてのその使用
WO1998018794A1 (fr) Nouveaux composes d'amide heterocycliques et leur utilisation a des fins medicinales
JPH07505874A (ja) Ｈｌｅ阻害活性を有するラクタムペプチド
WO2002053534A1 (fr) Inhibiteurs de vla-4
JPH07300479A (ja) ベンゾ縮合ラクタム類
KR101562347B1 (ko) 시아노퀴놀린 유도체
CN101951766A (zh) 凋亡抑制蛋白抑制剂
CZ293825B6 (cs) ChinoxalinyŹ způsob jejich výroby a jejich použití a farmaceutické prostředky tyto látky obsahující
JP6395829B2 (ja) 新規イソインドリン又はイソキノリン化合物、それらの調製のためのプロセス及びそれらを含有する医薬組成物
UA73530C2 (uk) Сполука з властивостями вивільнювати гормон росту
EP0753004A1 (en) Antagonists of endothelin receptors
JPH08277270A (ja) Ａｃｅおよびｎｅｐの抑制に有用なアゼピノン化合物
TW200406400A (en) Pyridazinone compound and pharmaceutical use thereof
ES2221989T3 (es) Compuestos de benzo(5,6)cicloheptapiridina utiles como inhibidores de la farnesil-protein-transferasa.
US20040006065A1 (en) Bicyclic pyrimidinones as coagulation cascade inhibitors
NZ527189A (en) Peptide compounds for use in prophylactic and therapeutic treatment of NO-mediated diseases
JPH0748370A (ja) 新規複素環化合物